2型糖尿病患者颈动脉内膜增厚的相关危险因素分析(3)
| 第1页 |
参见附件。
[2] Yanagisawa K，Ashihara J，Obara S，et al.Switching to multiple daily injection therapy with glulisine improves glycemic control，vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients[J].Diabetes Metab Res Rev，2014，doi：10.1002/dmrr.2537.[Epub ahead of print]
[3] Yamasaki Y，Kodama M，Nishizawa H，et al.Carotid intima-media thickness in Japanese type 2 diabetic subjects：predictors of progression and relationship with incident coronary heart disease[J].Diabetes Care， 2000，23(9)：1310-1315.
[4] Mitsuhashi N，Onuma T，Kubo S，et al.Coronary artery disease and carotid artery intima-media thickness in Japanese type 2 diabetic patients[J].Diabetes Care，2002， 25(8)：1308-1312.
[5] Mudríková T，Szabová E，Tkác I.Carotid intima-media thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus[J].Wien Klin Wochenschr，2000，112(20)：887-891.
[6] Prendergast C，Gidding SS.Cardiovascular risk in children and adolescents with type 2 diabetes mellitus[J].Curr Diab Rep，2014，14(2)：454.
[7] Schauer IE，Snell-Bergeon JK，Bergman BC，et al.Insulin resistance，defective insulin-mediated fatty acid suppression，and coronary artery calcification in subjects with and without type 1 diabetes：the CACTI study[J].Diabetes，2011， 60(1)：306-314.
[8] Matikainen N，Taskinen MR.Management of dyslipidemias in the presence of the metabolic syndrome or type 2 diabetes[J].Curr Cardiol Rep，2012，14(6)：721-731.
[9] Magge SN.Cardiovascular risk in children and adolescents with type 1 and type 2 diabetes mellitus[J].Curr Cardiovasc Risk Rep，2012，6(6)：591-600.
(收稿日期：2014-02-08 本文编辑：袁 成)
您现在查看是摘要介绍页，详见PDF附件。